Effect of medical castration on CYP3A4 enzyme activity using the erythromycin breath test

[1]  N. Saijo,et al.  Randomized pharmacokinetic and pharmacodynamic study of docetaxel: dosing based on body-surface area compared with individualized dosing based on cytochrome P450 activity estimated using a urinary metabolite of exogenous cortisol. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  E. Messing,et al.  Androgen deprivation therapy for prostate cancer: Current status and future prospects , 2004, The Prostate.

[3]  C. Tangen,et al.  Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer. , 2004, The New England journal of medicine.

[4]  I. Tannock,et al.  Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. , 2004, The New England journal of medicine.

[5]  R. Obach,et al.  Validated assays for human cytochrome P450 activities. , 2004, Drug metabolism and disposition: the biological fate of chemicals.

[6]  J. Verweij,et al.  Effect of Cytochrome P450 3A4 Inhibition on the Pharmacokinetics of Docetaxel , 2004, Clinical pharmacology and therapeutics.

[7]  D. Greenblatt,et al.  In vitro metabolism of midazolam, triazolam, nifedipine, and testosterone by human liver microsomes and recombinant cytochromes p450: role of cyp3a4 and cyp3a5. , 2003, Drug metabolism and disposition: the biological fate of chemicals.

[8]  P. Watkins.  Erythromycin breath test. , 2000, Clinical pharmacology and therapeutics.

[9]  P. Watkins,et al.  Erythromycin breath test (multiple letters) , 2000 .

[10]  S. Waldman,et al.  Concurrent Administration of the Erythromycin Breath Test (EBT) and Oral Midazolam as In Vivo Probes for CYP3A Activity , 1999, Journal of clinical pharmacology.

[11]  V. Hasselblad,et al.  Relative effectiveness and cost-effectiveness of methods of androgen suppression in the treatment of advanced prostate cancer. , 1999, Evidence report/technology assessment.

[12]  D. Wagner,et al.  CYP3A4 and the erythromycin breath test , 1998, Clinical pharmacology and therapeutics.

[13]  S. Waldman,et al.  Effect of Multiple Doses of Rifampin on the [14C N‐methyl] Erythromycin Breath Test in Healthy Male Volunteers , 1998, Journal of clinical pharmacology.

[14]  S. Wrighton,et al.  Identification of the human hepatic cytochromes P450 involved in the in vitro oxidation of antipyrine. , 1996, Drug metabolism and disposition: the biological fate of chemicals.

[15]  E. Vesell,et al.  Sexual dimorphism of nicotine metabolism and distribution in the rat. Studies in vivo and in vitro. , 1988, Drug metabolism and disposition: the biological fate of chemicals.

[16]  R B Schoene,et al.  Influence of body size and gender on control of ventilation. , 1986, Journal of applied physiology.

[17]  J. Kampmann,et al.  Enzyme induction by oral testosterone , 1976, Clinical pharmacology and therapeutics.